TransDermal Technologies, Inc.

Liquid Transdermal Drug Delivery Technology Licensing and OTC Topical Analgesics. TransDermal Technologies, Inc. has developed innovative pharmaceutical solutions and products through the application of a new and unique drug delivery technology called the Transdermal Delivery System (TDS(tm)). This drug delivery breakthrough is a liquid vehicle applied directly to the skin, not requiring a patch or other appliance. The medicine is delivered rapidly and in sufficient doses to accomplish a therapeutic outcome at one seventh to one tenth an equivalent oral dose. TDS(tm) has not yet encountered an upper bound for size of molecule it can deliver in solution in the system across the skin.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Drug delivery
- Generics
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: